BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Strong CL, Guerra HP, Mathew KR, Roy N, Simpson LR, Schiller MR. Damaging the Integrated HIV Proviral DNA with TALENs. PLoS One 2015;10:e0125652. [PMID: 25946221 DOI: 10.1371/journal.pone.0125652] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Abana CZ, Lamptey H, Bonney EY, Kyei GB. HIV cure strategies: which ones are appropriate for Africa? Cell Mol Life Sci 2022;79:400. [PMID: 35794316 DOI: 10.1007/s00018-022-04421-z] [Reference Citation Analysis]
2 Kim TH, Lee SW. Therapeutic Application of Genome Editing Technologies in Viral Diseases. Int J Mol Sci 2022;23:5399. [PMID: 35628210 DOI: 10.3390/ijms23105399] [Reference Citation Analysis]
3 Benjamin R, Banerjee A, Wu X, Geurink C, Buczek L, Eames D, Trimidal SG, Pluth JM, Schiller MR. XRCC4 and MRE11 Roles and Transcriptional Response to Repair of TALEN-Induced Double-Strand DNA Breaks. Int J Mol Sci 2022;23:593. [PMID: 35054780 DOI: 10.3390/ijms23020593] [Reference Citation Analysis]
4 Xun J, Zhang X, Guo S, Lu H, Chen J. Editing out HIV: application of gene editing technology to achieve functional cure. Retrovirology 2021;18:39. [PMID: 34922576 DOI: 10.1186/s12977-021-00581-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Khalid K, Padda J, Wijeratne Fernando R, Mehta KA, Almanie AH, Al Hennawi H, Padda S, Cooper AC, Jean-Charles G. Stem Cell Therapy and Its Significance in HIV Infection. Cureus 2021;13:e17507. [PMID: 34595076 DOI: 10.7759/cureus.17507] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Bhardwaj A, Nain V. TALENs-an indispensable tool in the era of CRISPR: a mini review. J Genet Eng Biotechnol 2021;19:125. [PMID: 34420096 DOI: 10.1186/s43141-021-00225-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
7 Ratti V, Nanda S, Eszterhas SK, Howell AL, Wallace DI. A mathematical model of HIV dynamics treated with a population of gene-edited haematopoietic progenitor cells exhibiting threshold phenomenon. Math Med Biol 2020;37:212-42. [PMID: 31265056 DOI: 10.1093/imammb/dqz011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Schwarzer R, Gramatica A, Greene WC. Reduce and Control: A Combinatorial Strategy for Achieving Sustained HIV Remissions in the Absence of Antiretroviral Therapy. Viruses 2020;12:E188. [PMID: 32046251 DOI: 10.3390/v12020188] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
9 Trimidal SG, Benjamin R, Bae JE, Han MV, Kong E, Singer A, Williams TS, Yang B, Schiller MR. Can Designer Indels Be Tailored by Gene Editing?: Can Indels Be Customized? Bioessays 2019;41:e1900126. [PMID: 31693213 DOI: 10.1002/bies.201900126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Llewellyn GN, Seclén E, Wietgrefe S, Liu S, Chateau M, Pei H, Perkey K, Marsden MD, Hinkley SJ, Paschon DE, Holmes MC, Zack JA, Louie SG, Haase AT, Cannon PM. Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1+ and TIGIT+ CD4 T Cells. J Virol 2019;93:e02086-18. [PMID: 30842333 DOI: 10.1128/JVI.02086-18] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
11 Preece R, Georgiadis C. Emerging CRISPR/Cas9 applications for T-cell gene editing. Emerg Top Life Sci 2019;3:261-75. [PMID: 33523139 DOI: 10.1042/ETLS20180144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Amsterdam D; Departments of Microbiology & Immunology, Medicine & Pathology, Jacobs School of Medicine & Biomedical Sciences, University at Buffalo, SUNY; Chief of Service, Laboratory Medicine, Erie County Medical Center Buffalo, NY, USA. . AIMS Allergy and Immunology 2018;2:113-25. [DOI: 10.3934/allergy.2018.3.113] [Reference Citation Analysis]
13 Trevisan M, Palù G, Barzon L. Genome editing technologies to fight infectious diseases. Expert Rev Anti Infect Ther 2017;15:1001-13. [PMID: 29090592 DOI: 10.1080/14787210.2017.1400379] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
14 Rogers GL, Cannon PM. Gene Therapy Approaches to Human Immunodeficiency Virus and Other Infectious Diseases. Hematol Oncol Clin North Am 2017;31:883-95. [PMID: 28895854 DOI: 10.1016/j.hoc.2017.06.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
15 Kwarteng A, Ahuno ST, Kwakye-Nuako G. The therapeutic landscape of HIV-1 via genome editing. AIDS Res Ther 2017;14:32. [PMID: 28705213 DOI: 10.1186/s12981-017-0157-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
16 Shankar S, Prasad D, Sanawar R, Das AV, Pillai MR. TALEN based HPV-E7 editing triggers necrotic cell death in cervical cancer cells. Sci Rep 2017;7:5500. [PMID: 28710417 DOI: 10.1038/s41598-017-05696-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
17 Huang Z, Tomitaka A, Raymond A, Nair M. Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS. Gene Ther. 2017;24:377-384. [PMID: 28471431 DOI: 10.1038/gt.2017.35] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
18 Xu W, Li H, Wang Q, Hua C, Zhang H, Li W, Jiang S, Lu L. Advancements in Developing Strategies for Sterilizing and Functional HIV Cures. Biomed Res Int 2017;2017:6096134. [PMID: 28529952 DOI: 10.1155/2017/6096134] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
19 Delhove JMKM, Qasim W. Genome-Edited T Cell Therapies. Curr Stem Cell Rep 2017;3:124-36. [PMID: 28596938 DOI: 10.1007/s40778-017-0077-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
20 Khalili K, White MK, Jacobson JM. Novel AIDS therapies based on gene editing. Cell Mol Life Sci 2017;74:2439-50. [PMID: 28210784 DOI: 10.1007/s00018-017-2479-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
21 Rodriguez HE, Lakshmi S, Somboonwit C, Oxner A, Guerra L, Addisu A, Gutierrez L, Sinnott JT, Nilofer C, Kangueane P, Shapshak P. Gene Therapy Blueprints for NeuroAIDS. Global Virology II - HIV and NeuroAIDS 2017. [DOI: 10.1007/978-1-4939-7290-6_37] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
22 Lusic M, Siliciano RF. Nuclear landscape of HIV-1 infection and integration. Nat Rev Microbiol 2017;15:69-82. [PMID: 27941817 DOI: 10.1038/nrmicro.2016.162] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 10.9] [Reference Citation Analysis]
23 Pernet O, Yadav SS, An DS. Stem cell-based therapies for HIV/AIDS. Adv Drug Deliv Rev 2016;103:187-201. [PMID: 27151309 DOI: 10.1016/j.addr.2016.04.027] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
24 Kishida T, Ejima A, Mazda O. Specific Destruction of HIV Proviral p17 Gene in T Lymphoid Cells Achieved by the Genome Editing Technology. Front Microbiol 2016;7:1001. [PMID: 27446041 DOI: 10.3389/fmicb.2016.01001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
25 Lucic B, Lusic M. Connecting HIV-1 integration and transcription: a step toward new treatments. FEBS Lett 2016;590:1927-39. [PMID: 27224516 DOI: 10.1002/1873-3468.12226] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
26 Benjamin R, Berges BK, Solis-Leal A, Igbinedion O, Strong CL, Schiller MR. TALEN gene editing takes aim on HIV. Hum Genet 2016;135:1059-70. [PMID: 27170155 DOI: 10.1007/s00439-016-1678-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 5.1] [Reference Citation Analysis]
27 Peng C, Lu M, Yang D. CRISPR/Cas9-based tools for targeted genome editing and replication control of HBV. Virol Sin. 2015;30:317-325. [PMID: 26511989 DOI: 10.1007/s12250-015-3660-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
28 Bose D, Gagnon J, Chebloune Y. Comparative Analysis of Tat-Dependent and Tat-Deficient Natural Lentiviruses. Vet Sci 2015;2:293-348. [PMID: 29061947 DOI: 10.3390/vetsci2040293] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
29 Ng TB, Cheung RC, Wong JH, Chan WY. Proteins, peptides, polysaccharides, and nucleotides with inhibitory activity on human immunodeficiency virus and its enzymes. Appl Microbiol Biotechnol 2015;99:10399-414. [PMID: 26411457 DOI: 10.1007/s00253-015-6997-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]